Fungal Infections in Gastroenterology
	 Volume 1 - Issue 3
		
		Michael AB Naafs MD*
		
		
		
		      - 
                
				Author Information
Open or Close
                
				
				
		- MD, Endocrinologist, Health Consultant at Naafs, International Health Consultancy, Rhodoslaan, Oldenzaal, The Netherlands
 *Corresponding author:  Michael AB Naafs, Dutch Internist Endocrinologist, Health Consultant at Naafs, International Health
Consultancy, Rhodoslaan 20,7577KN, Oldenzaal, The Netherlands
				 
 
 
 
 
			
			
			
				Received: August 13, 2018;   Published: August 20, 2018
             
      DOI:  10.32474/CTGH.2018.01.000114
			 
			   		
			   
			    Full Text
			   Full Text
			   
			   
			    PDF
			   PDF
			   
			   
				To view the Full Article    Peer-reviewed Article PDF
		
		Abstract
Fungal infections are increasing in gastroenterology. Cirrhotic patients, liver transplantation recipients, and patients with
inflammatory bowel disease (IBD) are vulnerable to these infections. The origin of these fungal infections is frequently the GI tract.
The advent of sequencing technology can identify now previously unculturable fungi. Dysbiosis of the mycobiome and microbiome
can uncheck normal commensal fungi and turn pathogenic by largely unknown mechanisms Resistance to antifungals is becoming
a global problem. New antifungals are in development and they are badly needed. In this mini-review the enteric mycobiota and
fungal infections in GI disease are discussed.
  
       
        
       
		
				    
 Abstract|
 Introduction|
 Conclusion|
References|